Sunday, 25 October 2020

Prolacta Bioscience Launches New Resources for Nurses, Clinicians Working with Premature Infants

Link
Share
Class
Send
Send
  • PRN | 3 years ago

DUARTE, Calif., Aug. 18, 2017 : Prolacta Bioscience, the nation's leading provider of human milk-based neonatal nutritional products to hospitals, has released several new resources for nurses and clinicians working with premature infants in the neonatal intensive care unit (NICU).


Educational and support resources include:
•Special Edition of Latch E-newsletter
◦The e-newsletter is published by Prolacta's Nursing Practice Advisory Council (NPAC), an advisory group of neonatal nursing leaders who are passionate about human milk science and nutrition.
◦The new edition of Latch is timed to coincide with Breastfeeding Awareness Month and focuses on mother's milk production, maintenance, staff support and advocacy for breastfeeding in the NICU.
◦Nurses and clinicians can sign up for the free newsletter at http://blog.prolacta.com/.
•Webinar on an Exclusive Human Milk Diet and Optimizing Nutrition
◦Prolacta has also released a new webinar, "Managing an Exclusive Human Milk Diet (EHMD)1 in Very Low Birth Weight Infants: Optimizing Enteral Nutrition."
◦Led by Dr. Melinda Elliott, Senior Director of Clinical Education and Professional Development at Prolacta, the webinar focuses on:
◾Short- and long-term benefits of an EHMD for premature infants;
◾The use of Prolacta's human milk-based fortifiers to ensure optimal protein, minerals and vitamins premature infants need;
◾Strategies to optimize nutrition to improve growth outcomes for very low birth weight infants.
◦Nurses and clinicians can register for the free webinar at http://prolacta-1.hs-sites.com/webinar/optimize-nutrition-for-growth-enduring.
•Webinar on Multi-Study Review of the Use of Human Milk-Derived Cream and Outcomes
◦Prolacta's Nutrition Advisory Committee (NAC) held a webinar on Wednesday, Aug. 16, on the "Multi-Study Review of The Use of Human Milk-Derived Cream in Very Low Birth Weight Infants and Outcomes."
◦The webinar focused on two articles on the use of Prolacta's human milk-derived cream to improve overall caloric intake without substantially altering the volume infants are fed.
•Webinar on Transitioning a NICU to an EHMD
◦A third webinar will be available on Wednesday, Sept. 20.
◦The webinar, titled: "Successfully Implementing an Exclusive Human Milk Diet in the NICU: A Nurse Director's Insights and Lessons Learned," will explain how hospitals can ease the transition to an EHMD into their NICUs.
◦Registration is free and available online at http://prolacta-1.hs-sites.com/webinar/onboard-in-5-weeks.

When used as part of an EHMD, Prolacta's neonatal nutritional products are clinically proven to improve health outcomes2,3,4 and reduce hospital costs5,6 for critically ill, extremely premature infants weighing between 500-1,250g (1 lb 1 oz to 2 lbs 12 oz) at birth, in the NICU, as compared to cow milk-based fortifier or cow milk-based preterm formula.

Prolacta Bioscience Launches New Resources for Nurses, Clinicians Working with Premature Infants

Liked This Article? Be The First To Share it!
Share
Class
Send
Send


Find any Critical Errors? Please Report It!



You May Also Like: